The tumor surroundings with excess lactate and fatty acids create a metabolic barrier for glycolytic effector cells and simultaneously promotes stability of regulatory T cells, which limits the effectiveness of anti-CTLA-4 checkpoint therapy [7, 33, 34]. Here, CTLA4 is linked to neoplasm.